Publication: 4683

Publication: 4683

Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: JCO Oncol Adv vol 3 (1) e2500107

Year:: 2026
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 15

Parents:: 4258 4609
Children:: None

Program:: CCP
Primary Committee:: Symptom Inter
Sec. Committees:: GI Health Outcomes

Pharmas:
Grants:: UG1CA189823, U10CA180868 (NRG Oncology); U10CA180888 (SWOG); R01CA235726

Corr. Author:
Authors:: Ellen M. Lavoie Smith Minji Lee Mary R. Scott Heshan Liu Shauna Hillman Tracy Rieken Rachel Wills Julian Diaz-Cobo Selina Chow Heidi D. Finnes Kathryn Ruddy Jeffrey Meyerhardt Eileen O'Reilly Tareq Al Baghdadi Narjust Florez Jordan Kharofa Rang Govindarajan Mohamedtaki Tejani Ki Chung David Zahrieh Charles Loprinzi Maryam Lustberg

Networks:: FL086, GREENVILLE, LAPS-AL002, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016, OH070

Study: Alliance-A221805
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: